Phase 2 Study of DS-8500a in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy and safety of DS-8500a compared with
placebo in Japanese patients with Type 2 Diabetes Mellitus.